Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials
出版年份 2021 全文链接
标题
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials
作者
关键词
-
出版物
BMC CANCER
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-14
DOI
10.1186/s12885-021-08323-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor Patients
- (2018) Pashtoon Murtaza Kasi et al. DRUGS
- Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials
- (2018) Cesare Gridelli et al. JOURNAL OF CLINICAL ONCOLOGY
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients
- (2018) A Matikas et al. ANNALS OF ONCOLOGY
- A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients
- (2017) Alessandro Morabito et al. LUNG CANCER
- Correlation of UGT1A1 * 28 and * 6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients
- (2016) Chalirmporn Atasilp et al. Drug Metabolism and Pharmacokinetics
- Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer
- (2016) Theodoros Foukakis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia
- (2016) M Li et al. PHARMACOGENOMICS JOURNAL
- Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses
- (2016) J M Campbell et al. PHARMACOGENOMICS JOURNAL
- Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
- (2015) Didier Meulendijks et al. LANCET ONCOLOGY
- Predicting paclitaxel-induced neutropenia using the DMET platform
- (2015) Annemieke JM Nieuweboer et al. PHARMACOGENOMICS
- An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel
- (2012) Toshitaka Uchiyama et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with metastatic non-small-cell lung cancer: a retrospective analysis in gemcitabine-plus-platinum-treated patients
- (2012) Seung Hun Jang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
- (2012) Cesare Gridelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-Induced Neutropenia Does Not Correlate With DNA Repair Gene Polymorphisms and Treatment Efficacy in Advanced Non–Small-Cell Lung Cancer Patients
- (2011) Vega Iranzo et al. Clinical Lung Cancer
- A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer
- (2010) Sara Margolin et al. ACTA ONCOLOGICA
- Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy
- (2010) Kohei Shitara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy
- (2010) Andre T. Brunetto et al. Journal of Thoracic Oncology
- Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03
- (2009) Y Kishida et al. BRITISH JOURNAL OF CANCER
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer
- (2009) A. Luciani et al. LUNG CANCER
- Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials
- (2009) Cesare Gridelli et al. LUNG CANCER
- The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients
- (2008) Cesare Gridelli et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More